MAGPRED-125 MG INJ contains Methylprednisolone Sodium Succinate 125 mg, a corticosteroid formulation used to help reduce inflammation and immune system activity in conditions where systemic corticosteroid therapy is medically indicated.
Methylprednisolone Sodium Succinate is a glucocorticoid that may be used in a range of inflammatory, allergic, and immune-mediated conditions. The injectable form is particularly useful when parenteral corticosteroid therapy is required.
Composition:
- Methylprednisolone Sodium Succinate – 125 mg
- Dosage form: Injection
Key Benefits / Uses:
- Helps reduce inflammation
- Helps suppress excessive immune responses
- Used for certain severe allergic and inflammatory conditions
- Suitable when injectable corticosteroid therapy is clinically required
- Commonly used in hospital and clinical settings under medical supervision
Important: MAGPRED-125 MG INJ is a prescription corticosteroid and should be administered only under the direction of a qualified healthcare professional. The dose and duration depend on the patient’s condition and clinical response. Prolonged or inappropriate corticosteroid use may cause significant side effects.
